SENS (Senseonics Holdings) Moat Score: 3/10 (As of Jul. 02, 2026)


SENS Senseonics Holdings Inc SENS
62 GF Score
Price $5.49
GF Value $14.10
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Senseonics Holdings Moat Score?

Senseonics Holdings SENS +2.24% 62 Moat Score is 3 as of Jul. 02, 2026. GuruFocus rates SENS with a GF Score™ of 62/100 and a GF Value™ of $14.10 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 846 Medical Devices & Instruments companies, Senseonics Holdings ranks better than 75.89% on this metric.

Senseonics Holdings has the Moat Score of 3, which implies that the company might have No Moat - Very weak/transient advantages.

Senseonics Holdings has No Moat: Senseonics Holdings Inc has a very weak competitive position with limited market share and customer loyalty. It lacks significant intellectual property and regulatory barriers, and its innovation capabilities are not impactful enough to establish a durable moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Senseonics Holdings might have No Moat - Very weak/transient advantages.

Senseonics Holdings  (NAS:SENS) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Senseonics Holdings Moat Score Related Terms

SENS vs LAB, TMCI, SGHT: Moat Score Comparison

For the Medical Devices subindustry, Senseonics Holdings's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Senseonics Holdings Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Senseonics Holdings's Moat Score distribution charts can be found below:

* The bar in red indicates where Senseonics Holdings's Moat Score falls into.


SENS
62GF Score
Senseonics Holdings Inc SENS
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 3 mean?
Senseonics Holdings (SENS) has a Moat Score of 3 as of Jul. 02, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Senseonics Holdings ranks #204 out of 846 companies in the Medical Devices & Instruments industry, placing it in the top 24.1%.
Is Senseonics Holdings' Moat Score too high?
Senseonics Holdings' current Moat Score is 3. Based on the distribution chart, Senseonics Holdings ranks #204 out of 846 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Senseonics Holdings has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Senseonics Holdings' Moat Score compare to LAB and TMCI?
According to the Medical Devices & Instruments industry distribution chart, Senseonics Holdings ranks #204 out of 846 companies for Moat Score. This places Senseonics Holdings in the top 24% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Senseonics Holdings's current Moat Score is 3. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senseonics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Senseonics Holdings (SENS) is currently considered Possible Value Trap. The stock's GF Value™ is $14.10, compared to a current price of $5.49 — trading 61.1% below its estimated fair value. The current Moat Score is 3. Senseonics Holdings' overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Senseonics Holdings (SENS), the current Moat Score is 3 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Senseonics Holdings (SENS) Overvalued in 2026?

Based on GuruFocus' analysis, Senseonics Holdings stock appears to be undervalued. The current stock price of $5.49 is trading 61.1% below its estimated GF Value™ of $14.10. GuruFocus considers Senseonics Holdings to be Possible Value Trap.

Key valuation signals for SENS:

  • Moat Score: 3
  • GF Value™: $14.10 vs. price of $5.49 (61.1% below fair value)
  • GF Score™: 62/100 with 3 warning signs

No single metric tells the full story. See the SENS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Senseonics Holdings Business Description

Other Exchanges 6L60:Germany
Address 20451 Seneca Meadows Parkway, Germantown, MD, USA, 20876-7005
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.
62GF Score

Get the complete analysis for SENS

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.49
Price
$14.10
GF Value